Agenus Inc.
(NASDAQ : AGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.44%91.091.3%$816.44m
AMGNAmgen Inc.
1.01%188.861.2%$646.98m
GILDGilead Sciences, Inc.
0.35%67.000.9%$517.89m
BIIBBiogen Inc.
0.35%334.181.3%$453.13m
ILMNIllumina, Inc.
-0.80%299.833.5%$321.35m
REGNRegeneron Pharmaceuticals, Inc.
-0.25%419.562.6%$309.86m
VRTXVertex Pharmaceuticals Incorporated
0.36%187.531.9%$272.65m
ALXNAlexion Pharmaceuticals, Inc.
0.50%129.572.0%$236.71m
SRPTSarepta Therapeutics, Inc.
0.88%141.5015.4%$159.69m
AAgilent Technologies, Inc.
0.67%78.041.6%$143.35m
EXASExact Sciences Corporation
-2.37%83.5525.3%$127.56m
INCYIncyte Corporation
-0.45%83.702.5%$116.03m
ARRYArray BioPharma Inc.
0.61%23.248.2%$111.15m
EXELExelixis, Inc.
-0.42%21.266.4%$84.16m
NBIXNeurocrine Biosciences, Inc.
-0.36%80.605.1%$82.35m

Company Profile

Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes AGEN1884, Next-gen CTLA-A, AGEN2034, INCAGN1876, INCAGN1949, Prophage, AutoSynVax, PhosphoSynVax, and AS-21 Stimulon. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA.